Renal hemodynamic response to intrarenal infusion of calcitonin gene-related peptide in dogs

Daniel Villarreal, Ronald H. Freeman, Kenneth M. Verburg, Michael W Brands

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

The renal hemodynamic and excretory effects of intrarenal infusions of synthetic β-human calcitonin gene-related peptide (β-hCGRP) were examined in normal sodium replete dogs (Group 1, n=6), in sodium replete dogs pretreated with indomethacin (Group 2, n=6), and in sodium deplete dogs (Group 3, n=5). In all groups of anesthetized dogs β-hCGRP was infused at 5 and 10 ng·kg-1·min-1 for 50 min periods each. In the sodium replete group, β-hCGRP infusions strikingly increased renal blood flow, but this response was markedly attenuated in the other 2 groups. During β-hCGRP infusions, the clearance of creatinine also increased significantly in the sodium replete and deplete groups, but not in the indomethacin pretreated animals. No consistent changes in urinary sodium excretion or plasma renin activity were observed with β-hCGRP infusions in any of the 3 groups of dogs. These results indicate that β-hCGRP is a potent renal vasodilator and can increase renal blood flow and glomerular filtration. The data also suggest that the renal hemodynamic actions of β-hCGRP are partially mediated by renal prostaglandins, and that the vasodilatory effects of β-hCGRP may be antagonized by high circulating levels of endogenous angiotensin II in sodium-volume depletion. Finally, β-hCGRP does not appear to have significant actions on urinary sodium excretion or plasma renin activity under the experimental conditions of the present study.

Original languageEnglish (US)
Pages (from-to)1129-1135
Number of pages7
JournalPeptides
Volume9
Issue number5
DOIs
StatePublished - Jan 1 1988
Externally publishedYes

Fingerprint

Calcitonin Gene-Related Peptide
Hemodynamics
Sodium
Dogs
Kidney
Renal Circulation
Renin
Indomethacin
Blood
Plasmas
Vasodilator Agents
Angiotensin II
Prostaglandins
Creatinine
Animals

Keywords

  • Creatinine clearance
  • Prostaglandin synthesis inhibition
  • Renal sodium excretion
  • Sodium depletion

ASJC Scopus subject areas

  • Biochemistry
  • Physiology
  • Endocrinology
  • Cellular and Molecular Neuroscience

Cite this

Renal hemodynamic response to intrarenal infusion of calcitonin gene-related peptide in dogs. / Villarreal, Daniel; Freeman, Ronald H.; Verburg, Kenneth M.; Brands, Michael W.

In: Peptides, Vol. 9, No. 5, 01.01.1988, p. 1129-1135.

Research output: Contribution to journalArticle

Villarreal, Daniel ; Freeman, Ronald H. ; Verburg, Kenneth M. ; Brands, Michael W. / Renal hemodynamic response to intrarenal infusion of calcitonin gene-related peptide in dogs. In: Peptides. 1988 ; Vol. 9, No. 5. pp. 1129-1135.
@article{ec827d443dfe4bf49182bd9a90811717,
title = "Renal hemodynamic response to intrarenal infusion of calcitonin gene-related peptide in dogs",
abstract = "The renal hemodynamic and excretory effects of intrarenal infusions of synthetic β-human calcitonin gene-related peptide (β-hCGRP) were examined in normal sodium replete dogs (Group 1, n=6), in sodium replete dogs pretreated with indomethacin (Group 2, n=6), and in sodium deplete dogs (Group 3, n=5). In all groups of anesthetized dogs β-hCGRP was infused at 5 and 10 ng·kg-1·min-1 for 50 min periods each. In the sodium replete group, β-hCGRP infusions strikingly increased renal blood flow, but this response was markedly attenuated in the other 2 groups. During β-hCGRP infusions, the clearance of creatinine also increased significantly in the sodium replete and deplete groups, but not in the indomethacin pretreated animals. No consistent changes in urinary sodium excretion or plasma renin activity were observed with β-hCGRP infusions in any of the 3 groups of dogs. These results indicate that β-hCGRP is a potent renal vasodilator and can increase renal blood flow and glomerular filtration. The data also suggest that the renal hemodynamic actions of β-hCGRP are partially mediated by renal prostaglandins, and that the vasodilatory effects of β-hCGRP may be antagonized by high circulating levels of endogenous angiotensin II in sodium-volume depletion. Finally, β-hCGRP does not appear to have significant actions on urinary sodium excretion or plasma renin activity under the experimental conditions of the present study.",
keywords = "Creatinine clearance, Prostaglandin synthesis inhibition, Renal sodium excretion, Sodium depletion",
author = "Daniel Villarreal and Freeman, {Ronald H.} and Verburg, {Kenneth M.} and Brands, {Michael W}",
year = "1988",
month = "1",
day = "1",
doi = "10.1016/0196-9781(88)90100-3",
language = "English (US)",
volume = "9",
pages = "1129--1135",
journal = "Peptides",
issn = "0196-9781",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - Renal hemodynamic response to intrarenal infusion of calcitonin gene-related peptide in dogs

AU - Villarreal, Daniel

AU - Freeman, Ronald H.

AU - Verburg, Kenneth M.

AU - Brands, Michael W

PY - 1988/1/1

Y1 - 1988/1/1

N2 - The renal hemodynamic and excretory effects of intrarenal infusions of synthetic β-human calcitonin gene-related peptide (β-hCGRP) were examined in normal sodium replete dogs (Group 1, n=6), in sodium replete dogs pretreated with indomethacin (Group 2, n=6), and in sodium deplete dogs (Group 3, n=5). In all groups of anesthetized dogs β-hCGRP was infused at 5 and 10 ng·kg-1·min-1 for 50 min periods each. In the sodium replete group, β-hCGRP infusions strikingly increased renal blood flow, but this response was markedly attenuated in the other 2 groups. During β-hCGRP infusions, the clearance of creatinine also increased significantly in the sodium replete and deplete groups, but not in the indomethacin pretreated animals. No consistent changes in urinary sodium excretion or plasma renin activity were observed with β-hCGRP infusions in any of the 3 groups of dogs. These results indicate that β-hCGRP is a potent renal vasodilator and can increase renal blood flow and glomerular filtration. The data also suggest that the renal hemodynamic actions of β-hCGRP are partially mediated by renal prostaglandins, and that the vasodilatory effects of β-hCGRP may be antagonized by high circulating levels of endogenous angiotensin II in sodium-volume depletion. Finally, β-hCGRP does not appear to have significant actions on urinary sodium excretion or plasma renin activity under the experimental conditions of the present study.

AB - The renal hemodynamic and excretory effects of intrarenal infusions of synthetic β-human calcitonin gene-related peptide (β-hCGRP) were examined in normal sodium replete dogs (Group 1, n=6), in sodium replete dogs pretreated with indomethacin (Group 2, n=6), and in sodium deplete dogs (Group 3, n=5). In all groups of anesthetized dogs β-hCGRP was infused at 5 and 10 ng·kg-1·min-1 for 50 min periods each. In the sodium replete group, β-hCGRP infusions strikingly increased renal blood flow, but this response was markedly attenuated in the other 2 groups. During β-hCGRP infusions, the clearance of creatinine also increased significantly in the sodium replete and deplete groups, but not in the indomethacin pretreated animals. No consistent changes in urinary sodium excretion or plasma renin activity were observed with β-hCGRP infusions in any of the 3 groups of dogs. These results indicate that β-hCGRP is a potent renal vasodilator and can increase renal blood flow and glomerular filtration. The data also suggest that the renal hemodynamic actions of β-hCGRP are partially mediated by renal prostaglandins, and that the vasodilatory effects of β-hCGRP may be antagonized by high circulating levels of endogenous angiotensin II in sodium-volume depletion. Finally, β-hCGRP does not appear to have significant actions on urinary sodium excretion or plasma renin activity under the experimental conditions of the present study.

KW - Creatinine clearance

KW - Prostaglandin synthesis inhibition

KW - Renal sodium excretion

KW - Sodium depletion

UR - http://www.scopus.com/inward/record.url?scp=0024151211&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024151211&partnerID=8YFLogxK

U2 - 10.1016/0196-9781(88)90100-3

DO - 10.1016/0196-9781(88)90100-3

M3 - Article

VL - 9

SP - 1129

EP - 1135

JO - Peptides

JF - Peptides

SN - 0196-9781

IS - 5

ER -